NCT01947855 Post Prandial Glucose (PPG) Study of Empagliflozin in Japanese Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT01937871 A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED) Status COMPLETED Phase PHASE3
NCT01937026 A Study of Baricitinib and Probenecid in Healthy Participants Status COMPLETED Phase PHASE1
NCT01936376 A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers Status UNKNOWN Phase N/A
NCT01931475 A Study of Duloxetine in Participants With Chronic Pain Due to Osteoarthritis in China Status COMPLETED Phase PHASE3
NCT01929109 A Study of LY2409021 in Participants With Different Levels of Kidney Function Status COMPLETED Phase PHASE1
NCT01925989 A Study of How Insulin Peglispro (LY2605541) and Insulin Glargine Affect the Breakdown of Fat and Sugar in Type 1 Diabetics Status COMPLETED Phase PHASE1
NCT01925157 A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE1
NCT01925144 A Study of Baricitinib and Omeprazole in Healthy Participants Status COMPLETED Phase PHASE1
NCT01924299 A Study of Baricitinib When Administered With Ketoconazole or Fluconazole in Healthy Participants Status COMPLETED Phase PHASE1
NCT01921790 Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma Status UNKNOWN Phase PHASE2
NCT01919398 A Study of LY2940680 in Japanese Participants With Advanced Cancers Status COMPLETED Phase PHASE1
NCT01914666 An Open Label Extension Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain Status COMPLETED Phase PHASE3
NCT01913314 A Study of Carbon-14-Labeled LY2835219 ([^14C]-LY2835219) in Healthy Participants Status COMPLETED Phase PHASE1
NCT01910311 A Study of Baricitinib and Rifampicin in Healthy Participants Status COMPLETED Phase PHASE1
NCT01908582 A Study of Evacetrapib and Rifampin in Healthy Participants Status COMPLETED Phase PHASE1
NCT01903356 A Regulatory Requirement Non Interventional Study to Monitor Safety and Effectiveness of Trajenta Duo in Type 2 Diabetes Patients in Korea Status COMPLETED Phase N/A